(Q34557335)

3 August 2017

1 reference

title

Hyperprolactinemia: pathophysiology and management (English)

1 reference

3 August 2017

1 reference

Johan Verhelst

1

1 reference

3 August 2017

Roger Abs

series ordinal

2

1 reference

3 August 2017

publication date

1 January 2003

1 reference

Treatments in Endocrinology: guiding your management of endocrine disorders

3 August 2017

published in

1 reference

3 August 2017

volume

2

1 reference

3 August 2017

issue

1

1 reference

3 August 2017

page(s)

23-32

1 reference

Hyperprolactinaemia in males: a heterogeneous disorder.

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2165%2F00024677-200302010-00003

Drugs five years later. Bromocriptine

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00024677-200302010-00003

A giant prolactinoma presenting with unilateral exophthalmos: effect of cabergoline and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00024677-200302010-00003

Long-term treatment with cabergoline, a new long-lasting ergoline derivate, in idiopathic or tumorous hyperprolactinaemia and outcome of drug-induced pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00024677-200302010-00003

Cabergoline-induced CSF rhinorrhea in patients with macroprolactinoma. Report of three cases

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00024677-200302010-00003

10.2165/00024677-200302010-00003

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

3 August 2017

1048239817

0 references

Fatcat ID

release_pribp2usibasvj6phy3ilxthqe

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/pribp2usibasvj6phy3ilxthqe

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference